|
Index of reports
> Life Threatening Events (116)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 116 Next >>
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Start date: 2012-07-27
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Indication: Medulloblastoma
Start date: 2012-07-26
End date: 2012-07-26
Cisplatin
Dosage: 3.5 mg/kg/day over 6 hours on day 4
Start date: 2012-07-02
End date: 2012-07-02
Cyclophosphamide
Dosage: 60 mg/kg/day over 1 hour on day 5 and 6
Indication: Medulloblastoma
Start date: 2012-07-27
End date: 2012-07-28
Cyclophosphamide
Dosage: 60 mg/kg/day over 1 hour on day 5 and 6
Start date: 2012-07-03
End date: 2012-07-04
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Start date: 2012-07-02
End date: 2012-07-04
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Start date: 2012-07-29
Etoposide
Dosage: 2.5 mg/kg/day on days 4,5 and 6
Indication: Medulloblastoma
Start date: 2012-07-26
End date: 2012-07-28
Furosemide
Dosage: 5 mg, qd
Start date: 2012-07-28
End date: 2012-07-29
Isotretinoin
Dosage: 80 mg/m2/dose, bid on days 1-4
Administration route: Oral
Indication: Medulloblastoma
Start date: 2012-07-23
End date: 2012-07-27
Isotretinoin
Dosage: 80 mg/m2/dose, bid on days 1-4
Administration route: Oral
Start date: 2012-06-29
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Start date: 2012-07-02
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Indication: Medulloblastoma
Start date: 2012-07-23
Vincristine
Dosage: 0.05 mg/kg/day on days 4 11 and 18
Start date: 2012-07-27
Vorinostat
Dosage: 230 mg/m2/dose on days 1-4
Administration route: Oral
Start date: 2012-06-29
Vorinostat
Dosage: 230 mg/m2/dose on days 1-4
Administration route: Oral
Indication: Medulloblastoma
Start date: 2012-07-23
End date: 2012-07-25
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Vincristine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in 9 year old male
Reported by a physician from United States on 2012-08-17
Patient: 9 year old male
Reactions: Respiratory Failure, Disseminated Cryptococcosis, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: daily
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Pegaspargase
Dosage: single dose
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: weekly
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in 60 year old female
Reported by a physician from Czech Republic on 2012-08-17
Patient: 60 year old female
Reactions: Headache, Full Blood Count Decreased, Myopathy, Gastrointestinal Disorder, Platelet Count Decreased, Brain Oedema, Cerebral Hygroma, Intracranial Pressure Increased, Fluid Retention
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: unk
Start date: 2012-06-25
Imatinib Mesylate
Dosage: unk ukn, unk
Imatinib Mesylate
Dosage: 600 mg, daily
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-28
Vincristine
Dosage: unk
Start date: 2012-06-25
Other drugs received by patient: Dexamethasone; Degan; Piperacillin and Tazobactam; Mykofungin; Zoloft; TPN; Neupogen; Cyclophosphamide; Torecan; Sulfamethoxazole and Trimethoprim; Omeprazole
Possible Vincristine side effects in female
Reported by a physician from France on 2012-08-14
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Pulmonary Oedema, Myocardial Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Cyclophosphamide
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Istodax
Dosage: 22 milligram
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Prednisone TAB
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Vincristine
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Other drugs received by patient: Gemox
Possible Vincristine side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: female
Reactions: Septic Shock, Splenic Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Nodal Marginal Zone B-Cell Lymphoma
Start date: 2012-06-29
End date: 2012-06-29
Prednisone TAB
Dosage: 1 tablet
Administration route: Oral
Indication: Nodal Marginal Zone B-Cell Lymphoma
Start date: 2012-06-28
Vincristine
Dosage: 1 unit
Indication: Nodal Marginal Zone B-Cell Lymphoma
Start date: 2012-06-29
End date: 2012-06-29
Other drugs received by patient: Aspirin; Acetaminophen; Fasturtec; Pravastatine Arrow; Venlafaxine; Potassium Chloride; Ramipril; Nexium; Bisoprolol Fumarate
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-08-09
Patient:
Reactions: Small Intestinal Obstruction, Vomiting, Nausea, Abdominal Pain Upper
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1340 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Doxorubicin Hydrochloride
Dosage: 90 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Prednisolone
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Rituximab
Dosage: 670 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Velcade
Dosage: 2.3 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-30
End date: 2012-06-08
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Other drugs received by patient: Acyclovir; Allopurinol; Amitriptyline HCL; Omeprazole; Amitriptyline HCL; Metoclopramide; Metoclopramide
Possible Vincristine side effects in female
Reported by a physician from United Kingdom on 2012-08-08
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Meningitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-07
End date: 2012-06-13
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Possible Vincristine side effects in 74 year old male
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: 74 year old male
Reactions: Blood Bilirubin Increased, Pneumonia, Atrial Fibrillation, Hepatic Enzyme Increased, Death, Enterococcal Sepsis, Fluid Retention, Cardiac Failure Congestive
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Elspar
Methotrexate
Dosage: day15
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Sprycel
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-22
Vincristine
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Start date: 2008-04-08
Dexamethasone
Start date: 2008-06-01
End date: 2008-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2008-05-05
Dexamethasone
Start date: 2008-05-19
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-09-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2004-01-01
End date: 2008-01-01
Dexamethasone
Start date: 2008-04-08
End date: 2008-09-01
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-06-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Vincristine side effects in female
Reported by a physician from France on 2012-07-31
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Pulmonary Oedema, Myocardial Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Cyclophosphamide
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Istodax
Dosage: 22 milligram
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Prednisone TAB
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Vincristine
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2012-06-06
End date: 2012-06-06
Other drugs received by patient: Gemox
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-07-30
Patient:
Reactions: Small Intestinal Obstruction, Vomiting, Nausea, Abdominal Pain Upper
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1340 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Doxorubicin Hydrochloride
Dosage: 90 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Prednisolone
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Rituximab
Dosage: 670 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Velcade
Dosage: 2.3 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-30
End date: 2012-06-08
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-05-11
End date: 2012-05-30
Other drugs received by patient: Omeprazole; Metoclopramide; Amitriptyline Hydrochloride; Allopurinol; Amitriptyline Hydrochloride; Metoclopramide; Acyclovir
Possible Vincristine side effects in
Reported by a physician from Korea, Republic of on 2012-07-30
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxil
Dosage: 50 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Vincristine side effects in 79 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-30
Patient: 79 year old female
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-18
End date: 2012-06-18
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-18
End date: 2012-06-18
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-18
End date: 2012-06-18
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Prednisolone
Possible Vincristine side effects in female
Reported by a physician from United Kingdom on 2012-07-27
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Neutropenia, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Furosemide
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-27
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Meningitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-07
End date: 2012-06-13
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Possible Vincristine side effects in
Reported by a physician from Korea, Republic of on 2012-07-24
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxil
Dosage: 50 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Vincristine side effects in 17 year old male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-23
Patient: 17 year old male
Reactions: Abdominal Pain, Rhabdomyolysis, Pain in Extremity, Disseminated Intravascular Coagulation, Chromaturia, Pancytopenia, Pyrexia, Renal Failure, Renal Impairment, Diarrhoea, Clostridial Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Pyrexia
Doxorubicin HCL
Indication: Ewing's Sarcoma Metastatic
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Netilmicin Sulfate
Indication: Pyrexia
Vincristine
Indication: Ewing's Sarcoma Metastatic
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Vincristine side effects in
Reported by a physician from Korea, Republic of on 2012-07-18
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750.00 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxorubicin HCL
Dosage: 50.00 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100.00 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.40 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-07-18
Patient:
Reactions: Neutropenic Sepsis, Respiratory Arrest
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1300 mg, unk
Start date: 2010-11-05
Cyclophosphamide
Dosage: 1300 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
End date: 2010-11-05
Doxorubicin HCL
Dosage: 90 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Doxorubicin HCL
Dosage: 83 unk, unk
Start date: 2010-11-05
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
End date: 2010-11-05
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-11-05
Velcade
Dosage: 2.8 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Velcade
Dosage: 1.3 unk, unk
Start date: 2010-11-05
End date: 2010-11-12
Vincristine
Dosage: 2 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Other drugs received by patient: Metoclopramide; Simvastatin; Ramipril; Acyclovir; Piperacillin and Tazobactam; Fluoxetine HCL; E45; Aspirin; Gaviscon; Bisoprolol Fumarate; Omeprazole
Possible Vincristine side effects in 54 year old female
Reported by a physician from France on 2012-07-13
Patient: 54 year old female
Reactions: Leukaemia, Leukaemia Plasmacytic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: cumulative total dose of doxorubicine of 504 mg (300 mg/m2)
Indication: non-Hodgkin's Lymphoma
Start date: 2010-05-10
End date: 2010-08-16
Etoposide
Dosage: (500 mg)
Indication: non-Hodgkin's Lymphoma
Start date: 2010-01-01
End date: 2011-01-01
Ifosfamide
Dosage: 2480 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2010-01-01
End date: 2011-01-01
Mabthera
Dosage: 650 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2010-05-10
End date: 2010-08-16
Methotrexate
Dosage: (4500 mg)
Start date: 2012-05-14
Methotrexate
Indication: non-Hodgkin's Lymphoma
Start date: 2010-09-13
End date: 2010-09-28
Methylprednisolone
Indication: non-Hodgkin's Lymphoma
Start date: 2010-05-10
End date: 2010-08-16
Prednisone
Indication: non-Hodgkin's Lymphoma
Start date: 2010-05-10
End date: 2010-08-16
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2010-05-10
End date: 2010-08-16
Possible Vincristine side effects in female
Reported by a physician from United Kingdom on 2012-07-09
Patient: female, weighing 51.5 kg (113.3 pounds)
Reactions: Mucosal Inflammation, Acute Respiratory Distress Syndrome, Febrile Bone Marrow Aplasia, Encephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dactinomycin
Dosage: 2 mg
Indication: Sarcoma Metastatic
Start date: 2010-07-16
Doxorubicin HCL
Dosage: 92 mg
Indication: Sarcoma Metastatic
Start date: 2010-07-16
Doxorubicin HCL
Dosage: 30 mg/m2
Ifosfamide
Dosage: 6 g/m2
Indication: Sarcoma Metastatic
Start date: 2010-07-16
Ifosfamide
Dosage: 6 g,2
Start date: 2010-09-12
Vincristine
Dosage: 2 mg
Indication: Sarcoma Metastatic
Start date: 2010-07-16
Other drugs received by patient: Mutesa / 00858001 /; Lasix; Acetaminophen; Nicardipine HCL; Sufentanil Citrate; Xanax; Acetaminophen; Plitican; Emend; Omeprazole; Tramadol HCL; Albumin (Human); Bactrim
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-27
Patient:
Reactions: Angina Pectoris, Death, Ejection Fraction Decreased, Cardiotoxicity, Cardiovascular Disorder, Lymphoma, Myocardial Infarction, Infection
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Doxorubicin HCL
Dosage: average dose: 336,5 mg/m2 (range 50-680)
Indication: Lymphoma
Prednisolone
Indication: Lymphoma
Vincristine
Indication: Lymphoma
Possible Vincristine side effects in 46 year old female
Reported by a individual with unspecified qualification from Germany on 2012-06-21
Patient: 46 year old female
Reactions: Mucosal Inflammation, Respiratory Failure, General Physical Health Deterioration, Haemorrhagic Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Page 1 Next >>
|
